- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/48 - Iso-indolesHydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Patent holdings for IPC class C07D 209/48
Total number of patents in this class: 764
10-year publication summary
|
76
|
61
|
65
|
55
|
50
|
45
|
38
|
33
|
37
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17641 |
19 |
| Amgen Inc. | 4081 |
12 |
| Cancer Research Technology Limited | 525 |
11 |
| FUJIFILM Corporation | 29458 |
10 |
| The Scripps Research Institute | 1347 |
8 |
| SHPP Global Technologies B.V. | 1090 |
8 |
| Siemens Medical Solutions USA, Inc. | 1514 |
7 |
| ExxonMobil Chemical Patents Inc. | 3976 |
7 |
| Arvinas Operations, Inc. | 229 |
7 |
| Boehringer Ingelheim International GmbH | 4641 |
6 |
| Syngenta Participations AG | 1904 |
6 |
| Wisconsin Alumni Research Foundation | 3889 |
6 |
| Astex Therapeutics Limited | 239 |
6 |
| SABIC Global Technologies B.V. | 4353 |
6 |
| The Trustees of Princeton University | 1196 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2858 |
6 |
| Vectus Biosystems Limited | 35 |
6 |
| Zeon Corporation | 4079 |
6 |
| Massachusetts Institute of Technology | 10066 |
5 |
| Celgene Corporation | 1397 |
5 |
| Other owners | 611 |